Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
02/2007
02/15/2007CA2618631A1 Method for producing cercosporamide
02/15/2007CA2618622A1 Novel cercosporamide derivative
02/15/2007CA2618486A1 Ep2 receptor agonists
02/15/2007CA2616854A1 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
02/14/2007EP1751165A1 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones
02/14/2007EP1751127A2 Novel cylopenta¬b|benzofuran derivatives and the utilization thereof
02/14/2007EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
02/14/2007EP1126836B1 Benzamide potassium channel inhibitors
02/14/2007EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
02/14/2007EP0946478B1 Process for the solid phase synthesis of aldehydes, ketones and hydroxamic acid compounds
02/14/2007CN1914192A Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
02/14/2007CN1914188A Cationic substituted benzofurans as antimicrobial agents
02/14/2007CN1914187A Crystalline polymorphs of a CXC-chemokine receptor ligand
02/14/2007CN1913880A Method for treating ADAMTS-5-associated disease
02/14/2007CN1911922A Compound separated from petroleum ether extract of glycyrrhiza legume bacteria strain CCNWGX022 fermentation liquid
02/14/2007CN1300131C Separation method for purifying gibberellin GA3
02/14/2007CN1300130C Rosa banksiae general lactone extract and its preparing process and application
02/14/2007CN1300129C Compound of 3,15-dicarbonyl erythro mildew acid kind and its ester and salt
02/14/2007CN1300128C Synthesis method of 2-dicyano methylene-3-cyano-4,5,5-trimethyl-2,5-dihydrofurane
02/14/2007CN1300127C Process and device for producing furol by two step continuous low pressure high temperature dynamic hydrolysis method
02/14/2007CN1300126C Application of 3-hydroxyphenyl phthale compound in preparing culicifuge
02/14/2007CN1300110C Hydroxamate derives useful as deacetylase inhibitors
02/14/2007CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques
02/13/2007US7176324 1,1,2,3,3-pentamethyl-octahydro-spiro[1,3-dioxolane-2,4-(4H)indene]; or 4-Ethoxymethoxy-1,1,2,3,3-pentamethyl-2,3,4,5,6,7-hexahydro-1H-indene; fragrances, cosmetics, toiletries, cleaning product like detergents, for dishwashing, laundering
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
02/13/2007US7176236 Water-soluble etoposide analogs and methods of use thereof
02/13/2007US7176228 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/13/2007US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis
02/13/2007CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/13/2007CA2220649C 4-hydroxy-piperidine derivatives
02/13/2007CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents
02/08/2007WO2007014843A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor
02/08/2007WO2007014608A1 Quadratic acid ii derivatives
02/08/2007WO2006129318A3 Benzofuran derivatives with therapeutic activities
02/08/2007US20070032666 intermediate for side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones); 4-Bromo-5(bromomethylene)-3-(1-bromoethyl)-2(5H)-furanone from N-bromosuccinimide the 3-ethylfuranone
02/08/2007US20070032640 Cytokine receptor
02/08/2007US20070032483 Process for the production of mycophenolate mofetil
02/08/2007CA2616685A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor
02/08/2007CA2616669A1 Squaric acid derivatives_ii
02/07/2007EP1749831A1 Demethyl-cantharidin platinum complex isomers and their use
02/07/2007EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases
02/07/2007EP1749042A1 Method for producing elastomeric copolyesters
02/07/2007EP1748979A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
02/07/2007EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007EP1071677B1 Production of furanones
02/07/2007CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
02/07/2007CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
02/07/2007CN1910170A Aqueous polymer dispersions containing alkenyl succinic acid anhydrides, methods for the production thereof, and use of the same
02/07/2007CN1910169A 拟除虫菊酯杀虫剂 Pyrethroid insecticides
02/07/2007CN1907985A N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof
02/07/2007CN1298713C Process for the preparation of 5-substituted isobenzofurans
02/06/2007US7173142 Gaseous acid catalysis
02/06/2007US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts
02/06/2007US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid
02/06/2007US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones
02/06/2007US7173130 Detection of transmembrane potentials by optical methods
02/06/2007US7173061 For diagnosis or in vivo imaging of Amyloid-associated diseases such as diabetes; radiolabelled
02/06/2007US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
02/06/2007CA2362816C Valdecoxib compositions
02/01/2007WO2007014273A2 Sulfonamides as selective estrogen receptor modulators
02/01/2007WO2007012954A1 An improved process for the preparation of escitalopram
02/01/2007WO2006127871A3 Cycloalkylidene compounds as selective estrogen receptor modulators
02/01/2007US20070027138 Derivatives and analogs of galanthamine
02/01/2007US20070027116 Therapeutic phosphonate derivatives
02/01/2007US20070025366 Method and system for a low-overhead mobility management protocol in the internet protocol layer
02/01/2007DE102005035978A1 Katalysator und Verfahren zur Herstellung von Maleinsäureanhydrid Catalyst and process for the production of maleic anhydride
02/01/2007CA2616224A1 10-substituted tetracyclines and methods of use thereof
01/2007
01/31/2007EP1748046A2 Inhibitors of histone deacetylase
01/31/2007EP1748045A1 Light-emitting device material and light-emitting device
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1746888A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
01/31/2007CN1906186A Process for preparation of mycophenolic acid and ester derivatives thereof
01/31/2007CN1906185A Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
01/31/2007CN1906184A Mycophenolate mofetil impurity
01/31/2007CN1906183A N-acylsulfonamide apoptosis promoters
01/31/2007CN1903850A Method of preparing bismuth citrate ranitidine
01/31/2007CN1297551C New process for producing liquid methyl tetrahydro phthalic anhydride
01/31/2007CN1297550C Benzofuran derivatives, process for the preparation of the same and uses thereof
01/31/2007CN1297549C Method for preparing furfural from acidified filtrate of pulping black liquid
01/31/2007CN1297548C Cyclic hemiacetal derivative and use thereof
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/30/2007US7169953 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
01/30/2007US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
01/30/2007US7169816 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK
01/30/2007US7169796 Polyarylcarboxamides useful as lipid lowering agents
01/30/2007US7169732 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
01/30/2007US7169541 Compound, polymer, resist composition, and patterning process
01/30/2007CA2440383C 7,9-substituted tetracycline compounds
01/30/2007CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands
01/25/2007WO2007010838A1 Process for producing alkaline earth metal salt of (-)-hydroxycitric acid
01/25/2007WO2007009977A1 Polymerisation catalyst system based on dioxime ligands
01/25/2007WO2006117696A3 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
01/25/2007US20070021622 Production method of highly pure pyromellitic dianhydride
01/25/2007US20070021509 Phosphate transport inhibitors
01/25/2007US20070021499 S-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile; preparation of purified escitalopram free base and its salts using the crystalline base or hydrobromide of escitalopram; antidepressant ; Dissolving free base in diethylether and removing
01/25/2007US20070021495 Sulfonamides as selective estrogen receptor
01/25/2007US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
01/25/2007US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals